Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder
Michael D. Raleigh, Samantha J. King, Federico Baruffaldi, et al.
Neuropharmacology (2021) Vol. 195, pp. 108653-108653
Open Access | Times Cited: 20

Showing 20 citing articles:

Antibody Immunotherapies for Personalized Opioid Addiction Treatment
Eric H. Rosenn, Miriam Korlansky, Shahin Benyaminpour, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103522-103522
Closed Access
A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, et al.
Cell Reports (2023) Vol. 42, Iss. 2, pp. 112049-112049
Open Access | Times Cited: 13
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
James E. Barrett, Aryan Shekarabi, Saadet Inan
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1062-1118
Open Access | Times Cited: 12
Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl
Xiaoyi Chen, Li Wang, Xiao Ma, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116918-116918
Closed Access | Times Cited: 4
The Development of Opioid Vaccines as A Novel Strategy for the Treatment of Opioid Use Disorder and Overdose Prevention
Mustafa Tunçtürk, Shikha Kushwaha, Robin M. Heider, et al.
The International Journal of Neuropsychopharmacology (2025)
Open Access
Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing Fentanyl
Carly Baehr, Rajwana Jahan, Ann Gebo, et al.
Bioconjugate Chemistry (2025)
Closed Access
Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl
Isabella G. Romano, Brandi T. Johnson‐Weaver, Susan B. Core, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
Dustin Hicks, Carly Baehr, Pedro Silva-Ortiz, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 20
Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats
Carly Baehr, Christine Robinson, Andrew J. Kassick, et al.
ACS Omega (2022) Vol. 7, Iss. 19, pp. 16584-16592
Open Access | Times Cited: 19
Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats
Bethany Crouse, Mariah M. Wu, Valeria Gradinati, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 5, pp. 331-343
Open Access | Times Cited: 16
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP
Saadyah Averick, Andrew J. Kassick, Daihyun Song, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Endogenous opiates and behavior: 2021
Richard J. Bodnar
Peptides (2023) Vol. 164, pp. 171004-171004
Closed Access | Times Cited: 8
The Immunological and Pharmacokinetic Evaluation of Lipid-PLGA Hybrid Nanoparticle-Based Oxycodone Vaccines
Debra Walter, Y.ZH. Bian, He Hu, et al.
Biomaterials (2024) Vol. 313, pp. 122758-122758
Closed Access | Times Cited: 2
Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity
Rutger van der Schrier, Jack D. C. Dahan, Martijn Boon, et al.
Anesthesiology (2021) Vol. 136, Iss. 4, pp. 618-632
Open Access | Times Cited: 15
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder
Brian D. Kiluk, Bethea A. Kleykamp, Sandra D. Comer, et al.
JAMA Psychiatry (2022) Vol. 80, Iss. 1, pp. 84-84
Closed Access | Times Cited: 10
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder
Fatima A. Hamid, Cheryl L. Marker, Michael D. Raleigh, et al.
Vaccine (2022) Vol. 40, Iss. 23, pp. 3244-3252
Open Access | Times Cited: 7
A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanyl
Isabella G. Romano, Brandi T. Johnson‐Weaver, Susan B. Core, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood
Isabella G. Romano, Susan B. Core, Naomi Lee, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 471-480
Closed Access | Times Cited: 1
Is it possible to design a clinically viable heroin vaccine? The progress and pitfalls
Therese J. Ziaks, Candy S. Hwang
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 3, pp. 207-210
Closed Access | Times Cited: 2
An Epitope-Focused Trypanosome-Derived Vaccine Platform Elicits High-Affinity Antibodies and Immunity Against Fentanyl Effects
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
An Epitope-Focused Trypanosome-Derived Vaccine Platform Elicits High-Affinity Antibodies and Immunity Against Fentanyl Effects
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, et al.
SSRN Electronic Journal (2022)
Open Access
Page 1

Scroll to top